Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Indivior ( (INDV) ) just unveiled an update.
Indivior PLC has announced its participation in several upcoming investor events, including the Jefferies Global Healthcare Conference, Goldman Sachs Annual Global Healthcare Conference, and the Northland Growth Conference 2025. These events will feature one-on-one and group meetings with the company’s CEO and CFO, providing opportunities for investors to engage with Indivior’s leadership. This participation underscores Indivior’s proactive approach in engaging with investors and enhancing its visibility within the healthcare investment community.
More about Indivior
Indivior is a global pharmaceutical company focused on developing medicines to treat substance use disorders (SUD). The company aims to transform SUD from a global crisis into a recognized and treated chronic disease. Headquartered in Richmond, VA, Indivior operates in over 30 countries and employs more than 1,000 people worldwide.
For detailed information about INDV stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue